Huadong Medicine Co Ltd Asset Resilience Ratio
Huadong Medicine Co Ltd asset resilience ratio. Huadong Medicine Co Ltd (000963) has an Asset Resilience Ratio of 0.05% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Huadong Medicine Co Ltd (000963) defensive interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Huadong Medicine Co Ltd (2000–2017)
Asset resilience ratio of Huadong Medicine Co Ltd from 2000 to 2017. This chart shows how Huadong Medicine Co Ltd's Asset Resilience Ratio has changed over time. Read 000963 total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Huadong Medicine Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 000963 total asset value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥16.49 Million | 0.05% |
| Total Liquid Assets | CN¥16.49 Million | 0.05% |
Asset Resilience Insights
- Limited Liquidity: Huadong Medicine Co Ltd maintains only 0.05% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Huadong Medicine Co Ltd Industry Peers by Asset Resilience Ratio
Compare Huadong Medicine Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Galderma Group N
SW:GALD |
Drug Manufacturers - Specialty & Generic | 3.56% |
|
Enzymatica publ AB
ST:ENZY |
Drug Manufacturers - Specialty & Generic | 22.17% |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 9.04% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Walvax BioTech
SHE:300142 |
Drug Manufacturers - Specialty & Generic | 2.20% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
Huadong Medicine Co Ltd Asset Resilience Ratio by Year (2000–2017)
Huadong Medicine Co Ltd asset resilience ratio by year from 2000 to 2017. The table below shows the annual Asset Resilience Ratio data for Huadong Medicine Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2017-12-31 | 4.25% | CN¥680.00 Million ≈ $99.51 Million |
CN¥15.99 Billion ≈ $2.34 Billion |
+3.22pp |
| 2016-12-31 | 1.04% | CN¥150.00 Million ≈ $21.95 Million |
CN¥14.46 Billion ≈ $2.12 Billion |
+1.01pp |
| 2014-12-31 | 0.03% | CN¥2.50 Million ≈ $365.83K |
CN¥9.01 Billion ≈ $1.32 Billion |
-0.79pp |
| 2005-12-31 | 0.82% | CN¥16.86 Million ≈ $2.47 Million |
CN¥2.05 Billion ≈ $300.54 Million |
-0.13pp |
| 2004-12-31 | 0.95% | CN¥16.86 Million ≈ $2.47 Million |
CN¥1.77 Billion ≈ $258.79 Million |
+0.91pp |
| 2003-12-31 | 0.05% | CN¥661.00K ≈ $96.73K |
CN¥1.43 Billion ≈ $209.98 Million |
-9.11pp |
| 2000-12-31 | 9.16% | CN¥104.74 Million ≈ $15.33 Million |
CN¥1.14 Billion ≈ $167.32 Million |
-- |
About Huadong Medicine Co Ltd
Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. It operates through Pharmaceutical Industry, Pharmaceutical Business, Aesthetic Medicine, and Industrial Microbiology segments. The company distributes Chinese and western medicines, Chinese herbal medicines, and medical instruments; and immunosup… Read more